Articles

Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma

University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI
The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation, Division of Cancer Medicine, Houston, TX
Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA
The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation, Division of Cancer Medicine, Houston, TX
University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI
Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA
Memorial Sloan Kettering Cancer Center, New York, NY
Memorial Sloan Kettering Cancer Center, New York, NY
Memorial Sloan Kettering Cancer Center, New York, NY
University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI
Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, MA
Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, MA
Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, MA
Sylvester Comprehensive Cancer Center, Division of Transplantation and Cellular Therapy, Miami, FL
Sylvester Comprehensive Cancer Center, Division of Transplantation and Cellular Therapy, Miami, FL
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH
Mayo Clinic, Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Jacksonville, FL
Mayo Clinic, Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Jacksonville, FL
Mayo Clinic, Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Jacksonville, FL
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
City of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA
City of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA
City of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA
John Theurer Cancer Center at Hackensack Meridian Health, NJ, USA; Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ
John Theurer Cancer Center at Hackensack Meridian Health, NJ
University of Kansas Medical Center, Division of Hematologic Malignancies and Cellular Therapeutics, Westwood, KS
Levine Cancer Institute/Atrium Health, Charlotte, NC
Levine Cancer Institute/Atrium Health, Charlotte, NC
Vanderbilt-Ingram Cancer Center, Division of Hematology and Oncology, Nashville, TN
Vanderbilt-Ingram Cancer Center, Division of Hematology and Oncology, Nashville, TN
Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI
University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI
Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX
The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation, Division of Cancer Medicine, Houston, TX
Medical College of Wisconsin, BMT and Cellular Therapy Program, Division of Hematology and Oncology, Milwaukee, WI
City of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA
Haematologica Early view Jul 14, 2022 https://doi.org/10.3324/haematol.2022.281242